Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis. - Jones RA; Dunlop EA; Champion JD; Doubleday PF; Claessens T; Jalali Z; Seifan S; Perry IA; Giles P; Harrison O; Coull BJ; Houweling AC; et al. (Oncogene, 2025)